Trinity, Florida (May 20, 2016) — Congressman Gus Bilirakis recently toured Florida Cancer Affiliates’ new radiation and medical oncology center located at 3611 Little Road, Trinity, Florida 34655. During the tour of the facility Congressman Bilirakis discussed the legislative issues critical to the local oncology community and met with FCA oncologists.
Congressman Bilirakis had the opportunity to visit the state-of-the-art equipment, especially the Elekta Infinity, with the industry-leading Agiliti Multi-Leaf Collimator. Florida Cancer Affiliates and The US Oncology Network invested in the sophisticated technology to further expand cancer treatment capabilities for patients in the area..
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care. For more information about Elekta, please visit www.elekta.com.
About Florida Cancer Affiliates
Florida Cancer Affiliates (FCA) is a community-based radiation oncology, medical oncology, and hematology practice with convenient locations throughout Florida, from Naples and Ft. Myers to Trinity, Hudson, Brooksville, The Villages, Ocala and Panama City. The integrated clinical team of FCA employs the latest technologies and drug therapies to ensure patients receive advanced care close to home. The comprehensive treatment centers include outpatient treatment and diagnostic facilities providing chemotherapy, hematology services, radiation therapy including stereotactic, brachytherapy and PET/CT imaging, clinical research, pharmacy and laboratory, as well as financial counseling and patient support services.
The practice is committed to providing patients with the best and most advanced care available. They offer therapies proven to be effective, along with advanced diagnostic and treatment technologies. They also provide access to new investigational drugs through clinical trials. By participating in clinical trials that test new drugs or various combinations of treatments, patients have the opportunity to receive new therapies not yet available outside these clinical trials. To learn more about Florida Cancer Affiliates, go to www.floridacancer.com.
Florida Cancer Affiliates is united in healing with The US Oncology Network, one of the nation’s largest networks of integrated community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. As an affiliate of The US Oncology Network, FCA is united with nearly 1,000 physicians nationwide. Florida Cancer Affiliates participates in clinical trials through US Oncology Research, which has played a role in 50 FDA-approved cancer therapies, nearly one-third of all cancer therapies approved by the FDA to date. For more information, visit www.usoncology.com.